Similar Articles
551 Successful totally laparoscopic right trihepatectomy following conversion therapy for hepatocellular carcinoma: A case report
552 Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma
553 Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma
554 Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells
555 Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis
556 Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
557 Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
558 Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
559 High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation
560 Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA